PembrolizumabBullous pemphigoid: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00806-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：349 / 349

相关论文

共 50 条

[31] Durvalumab/pembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2019, 1756 (1) : 142 - 142
[32] Nivolumab/pembrolizumabBullous pemphigoid: 13 case reports
Reactions Weekly, 2021, 1843 (1) : 290 - 290
[33] PembrolizumabBullous pemphigoid-like skin reaction with refractory pruritus: case report
Reactions Weekly, 2019, 1748 (1) : 416 - 416
[34] Ipilimumab/Nivolumab/PembrolizumabBullous pemphigoid: 7 case reports
Reactions Weekly, 2025, 2050 (1) : 286 - 286
[35] Ipilimumab/methotrexate/pembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1617 (1) : 143 - 143
[36] Dacarbazine/pembrolizumabBullous pemphigoid like drug eruption with fatigue and dryness of skin: case report
Reactions Weekly, 2017, 1670 (1) : 98 - 98
[37] PembrolizumabBullous rash: case report
Reactions Weekly, 2021, 1877 (1) : 325 - 325
[38] Ipilimumab/pembrolizumabBullous pemphigoid and dermatitis herpetiformis: 2 case reports
Reactions Weekly, 2017, 1673 (1) : 216 - 216
[39] Nivolumab/pembrolizumabBullous pemphigoid and bullous eruption: 3 case reports
Reactions Weekly, 2017, 1673 (1) : 282 - 282
[40] Nivolumab/pembrolizumabBullous pemphigoid and bullous erythema multiforme: 5 case reports
Reactions Weekly, 2017, 1661 (1) : 251 - 251

← 1 2 3 4 5 →